12.09
-1.79%
Close of 9 Nov 2026, in CNY
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Zhejiang Jingxin Pharmaceutical Co
Its shares trade on Shenzhen under the ticker 002020.SZ. It has been listed since 15 July 2004. In the fiscal year to 31 December 2025, it reported revenue of CN¥4.07bn and net income of CN¥758.0m. At that date it held total assets of CN¥8.12bn and shareholders' equity of CN¥5.83bn.
Zhejiang Jingxin Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of active pharmaceutical ingredients and medical devices. The company is headquartered in Shaoxing, Zhejiang. The company went IPO on 2004-07-15. The firm's pharmaceutical products include chemical pharmaceuticals, traditional medicines, biological agents and bulk pharmaceutical chemicals. Its pharmaceutical products are mainly applied in cardiovascular sector, digestive tract sector and psychoneural sector, among others. The firm is also engaged in the research and development, manufacture and sales of medical devices. Its medical devices include clinical displays, diagnosis displays, endoscopic surgery displays and ultrasonic image displays, among others. The firm operates its businesses in both domestic and overseas markets.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Pharmaceuticals
- Listed since
- 15 Jul 2004
- Employees
- 4,101
- Website
- jingxinpharm.com ↗
Leadership
Pay as last reported
- Mr. Gang LuChairman of the Board, President, since 2023CN¥1.7m
- Mr. Nengneng WangVice Chairman of the Board, since 2008CN¥1.3m
- Ms. Meili ChenChief Financial Officer, Vice President, DirectorCN¥993,200
- Mr. Zhiping JinVice President, Director, since 2013CN¥1.5m
- Mr. Sheng LiuVice President, Chief Procurement OfficerCN¥862,600
- Mr. Junmin WangVice President, since 2010CN¥273,000
- Mr. Zhibin ZhuVice PresidentCN¥978,400
- Mr. Yunfei HongSecretary of the Board, Director of Strategic Development, Director, since 2022CN¥869,100
- Mr. Jian HouDirectorCN¥1.1m
- Mr. Wan HuDirector
- Mr. Xiaoping FanIndependent DirectorCN¥80,000
- Ms. Ying LeiIndependent Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Zhejiang Jingxin Pharmaceutical Co Ltd employs 4101 full-time staff members.
- The company produces chemical pharmaceuticals and traditional medicines for global markets.
- Medical devices include clinical displays and ultrasonic image displays for hospitals.
Weaknesses
- The firm is headquartered in Shaoxing, Zhejiang, which limits local talent.
- Listing occurred on 15 July 2004, indicating a mature but slow growth phase.
- Reliance on domestic markets may restrict immediate international revenue expansion potential.
Opportunities
- Expanding sales of bulk pharmaceutical chemicals in overseas markets offers growth.
- Increasing demand for cardiovascular sector treatments drives product development opportunities.
- Research and development of biological agents can enhance product portfolio diversity.
Threats
- Competition in the psychoneural sector may reduce market share significantly.
- Regulatory changes in the Health Care sector could increase compliance costs.
- Fluctuations in raw material prices impact the profitability of chemical drugs.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.